BORIONI, AURORA
BORIONI, AURORA
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.008 secondi).
No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-up
2020 Calza L, Borderi M, Colangeli V, Borioni A, Coladonato S, Granozzi B, Viale P
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir
2020 Calza L.; Colangeli V.; Borderi M.; Bon I.; Borioni A.; Volpato F.; Re M.C.; Viale P.
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-up | Calza L, Borderi M, Colangeli V, Borioni A, Coladonato S, Granozzi B, Viale P | 2020-01-01 | INFECTIOUS DISEASES | - | 1.01 Articolo in rivista | - |
Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir | Calza L.; Colangeli V.; Borderi M.; Bon I.; Borioni A.; Volpato F.; Re M.C.; Viale P. | 2020-01-01 | INFECTION | - | 1.01 Articolo in rivista | - |